HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bacterial Infections D001424 21 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases D001847 4 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Neoplasms D001932 15 associated lipids
Breast Neoplasms D001943 24 associated lipids
Calcinosis D002114 5 associated lipids
Candidiasis D002177 3 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Carcinosarcoma D002296 7 associated lipids
Cerebellar Neoplasms D002528 9 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Chu LC et al. Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats. 2011 Br J Anaesth pmid:21441243
Ribeiro PO et al. Apoptotic neurodegeneration and spatial memory are not affected by sedative and anaesthetics doses of ketamine/medetomidine combinations in adult mice. 2012 Br J Anaesth pmid:22362669
Li Y et al. Human uveal melanoma expresses NG2 immunoreactivity. 2003 Br J Ophthalmol pmid:12714409
Sjö LD et al. Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. 2006 Br J Ophthalmol pmid:16672329
Tulvatana W et al. Risk factors for conjunctival squamous cell neoplasia: a matched case-control study. 2003 Br J Ophthalmol pmid:12642297
Shimmura S et al. Microkeratome assisted deep lamellar keratoprosthesis. 2006 Br J Ophthalmol pmid:16597665
Thinda S et al. Polycarbonate membrane impression cytology: evidence for fluorescein staining in normal and dry eye corneas. 2010 Br J Ophthalmol pmid:20424211
Sawa M et al. Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green. 2004 Br J Ophthalmol pmid:15148220
Smith JR et al. Expression of vascular endothelial growth factor and its receptors in rosacea. 2007 Br J Ophthalmol pmid:17244661
Crosby MB et al. Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. 2011 Br J Ophthalmol pmid:20819828
Schnurrbusch UE et al. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. 2001 Br J Ophthalmol pmid:11520762
Delarive T et al. Aqueous dynamic and histological findings after deep sclerectomy with collagen implant in an animal model. 2003 Br J Ophthalmol pmid:14609829
Marback EF et al. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. 2003 Br J Ophthalmol pmid:14507753
Dua HS et al. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. 2005 Br J Ophthalmol pmid:15834076
Sheidow TG et al. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. 2000 Br J Ophthalmol pmid:10873988
Touhami A et al. Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia. 2005 Br J Ophthalmol pmid:15722301
Shimmura S et al. Transplantation of corneal endothelium with Descemet's membrane using a hyroxyethyl methacrylate polymer as a carrier. 2005 Br J Ophthalmol pmid:15665339
Kim SG et al. Histological changes in the temporomandibular joint in rabbits depending on the extent of mandibular lengthening by osteodistraction. 2004 Br J Oral Maxillofac Surg pmid:15544889
Varley I et al. Pinning out pathological specimens--are we risking an unnecessary escalation of treatment? 2015 Br J Oral Maxillofac Surg pmid:25799957
Umeda M et al. Experimental model of invasion and metastasis by orthotopic transplantation of oral squamous and adenoid cystic carcinomas into the tongue of nude mice. 2001 Br J Oral Maxillofac Surg pmid:11601820
Ma Y and Shen G Distraction osteogenesis after irradiation in rabbit mandibles. 2012 Br J Oral Maxillofac Surg pmid:22079566
Topping A et al. Successful reduction in skin damage resulting from exposure to the normal-mode ruby laser in an animal model. 2001 Br J Plast Surg pmid:11207126
Nayak BB et al. A microneurovascular study of the great saphenous vein in man and the possible implications for survival of venous flaps. 2000 Br J Plast Surg pmid:10738330
Leslie TA et al. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? 2008 Br J Radiol pmid:18559903
Luo B et al. Neuroradiological findings of intracranial schwannomas not arising from the stems of cranial nerves. 2004 Br J Radiol pmid:15569643
Chong S et al. Herpes simplex virus pneumonia: high-resolution CT findings. 2010 Br J Radiol pmid:20442279
Longo UG et al. Characteristics at haematoxylin and eosin staining of ruptures of the long head of the biceps tendon. 2009 Br J Sports Med pmid:18070808
Cahill RA et al. Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. 2004 Br J Surg pmid:15505871
Noguchi M Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. 2002 Br J Surg pmid:12445058
Arai K et al. Clinicopathological analysis of early gastric cancer with solitary lymph node metastasis. 2002 Br J Surg pmid:12390388
Salem AA et al. Evaluation of axillary lymph nodes using touch imprint cytology and immunohistochemistry. 2002 Br J Surg pmid:12390378
Smidt ML et al. Intraoperative scrape cytology of the sentinel lymph node in patients with breast cancer. 2002 Br J Surg pmid:12296899
Mizuno T et al. Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater. 2006 Br J Surg pmid:16363020
Motomura K et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. 2002 Br J Surg pmid:12153631
Osugi H et al. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. 2002 Br J Surg pmid:12081742
Braat AE et al. Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable. 2005 Br J Surg pmid:16231281
Noguchi M Sentinel lymph node biopsy and breast cancer. 2002 Br J Surg pmid:11851659
Rusby JE et al. Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. 2008 Br J Surg pmid:18844271
van Wely BJ et al. False-negative sentinel lymph node biopsy. 2008 Br J Surg pmid:18844270
Crombie N et al. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma. 2001 Br J Surg pmid:11578285
Shrikhande SV et al. Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis. 2003 Br J Surg pmid:14648737
Dhar DK et al. Prognostic significance of metastatic lymph node size in patients with gastric cancer. 2003 Br J Surg pmid:14648731
Wijeyaratne SM et al. Differences in the detection of cyclo-oxygenase 1 and 2 proteins in symptomatic and asymptomatic carotid plaques. 2001 Br J Surg pmid:11442526
Mofidi R et al. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. 2001 Br J Surg pmid:11442525
Nos C et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. 2003 Br J Surg pmid:14598414
Mizunuma H et al. The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity. 2003 Br. J. Cancer pmid:12771919
Tani N et al. Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. 2003 Br. J. Cancer pmid:12610521
van Etten B et al. Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion. 2003 Br. J. Cancer pmid:12610519
Graff BA et al. Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts. 2003 Br. J. Cancer pmid:12610516
Bocci G et al. Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. 2008 Br. J. Cancer pmid:18443598
Miyoshi N et al. Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis. 2009 Br. J. Cancer pmid:19904274
Yokota N et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. 2009 Br. J. Cancer pmid:19904262
Ah-Weng A et al. Dermatofibrosarcoma protuberans treated by micrographic surgery. 2002 Br. J. Cancer pmid:12454766
Oei AL et al. Surveillance of women at high risk for hereditary ovarian cancer is inefficient. 2006 Br. J. Cancer pmid:16495917
Onda T et al. Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. 2006 Br. J. Cancer pmid:16479256
Løvig T et al. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. 2002 Br. J. Cancer pmid:12232760
Mathioudaki K et al. The PRMT1 gene expression pattern in colon cancer. 2008 Br. J. Cancer pmid:19078953
Chiyomaru T et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. 2010 Br. J. Cancer pmid:20160723
Barnes NL et al. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. 2007 Br. J. Cancer pmid:17285134
Wang W et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. 2004 Br. J. Cancer pmid:15150600
Carlsson J et al. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. 2004 Br. J. Cancer pmid:15150568
Kouzu Y et al. Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. 2006 Br. J. Cancer pmid:16495930
Hekmatyar SK et al. ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice. 2010 Br. J. Cancer pmid:20842126
Nakayama N et al. KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. 2008 Br. J. Cancer pmid:19018267
van Etten B et al. Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras. 2002 Br. J. Cancer pmid:11875712
Kato T et al. Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. 2007 Br. J. Cancer pmid:17923874
Kuefer R et al. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. 2004 Br. J. Cancer pmid:14735205
Dales JP et al. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). 2004 Br. J. Cancer pmid:15026804
Nakayama K et al. Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential. 2004 Br. J. Cancer pmid:15026802
Lee KT et al. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. 2004 Br. J. Cancer pmid:15026801
Teh SK et al. Diagnostic potential of near-infrared Raman spectroscopy in the stomach: differentiating dysplasia from normal tissue. 2008 Br. J. Cancer pmid:18195711
Duda DG et al. Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis. 2002 Br. J. Cancer pmid:11875720
Millis RR et al. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. 2002 Br. J. Cancer pmid:11875706
Wang JJ et al. Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells. 2003 Br. J. Cancer pmid:14612915
Bing C et al. Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. 2006 Br. J. Cancer pmid:17047651
Graham K et al. Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. 2010 Br. J. Cancer pmid:20197764
Hori K and Saito S Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700). 2004 Br. J. Cancer pmid:14735207
Hofer MD et al. Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. 2004 Br. J. Cancer pmid:14735193
Kahlert C et al. Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. 2009 Br. J. Cancer pmid:19603023
Yoshikawa D et al. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. 2008 Br. J. Cancer pmid:18087285
Escaff S et al. Study of matrix metalloproteinases and their inhibitors in prostate cancer. 2010 Br. J. Cancer pmid:20160732
Myers E et al. A positive role for PEA3 in HER2-mediated breast tumour progression. 2006 Br. J. Cancer pmid:17060941
Siriwardena BS et al. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. 2006 Br. J. Cancer pmid:17060937
Lee JW et al. BRAF mutations in non-Hodgkin's lymphoma. 2003 Br. J. Cancer pmid:14612909
Oehler MK et al. Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. 2003 Br. J. Cancer pmid:14612905
Shimada K et al. Aberrant expression of RAB1A in human tongue cancer. 2005 Br. J. Cancer pmid:15870709
Moye VE et al. Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines. 2004 Br. J. Cancer pmid:15150606
Hata K et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. 2003 Br. J. Cancer pmid:14520452
Harada K et al. Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features. 2007 Br. J. Cancer pmid:17923875
Dzięgiel P et al. Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases. 2010 Br. J. Cancer pmid:20648017
Fang DD et al. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. 2010 Br. J. Cancer pmid:20332776
Tasaki M et al. ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer. 2011 Br. J. Cancer pmid:21285982
Akagi T et al. Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells. 2008 Br. J. Cancer pmid:18682709
Kita Y et al. Expression of osteopontin in oesophageal squamous cell carcinoma. 2006 Br. J. Cancer pmid:16880782
de Graeff P et al. Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies. 2006 Br. J. Cancer pmid:16880779
Hsiao JR et al. Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. 2003 Br. J. Cancer pmid:12865928
Fukushima N et al. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. 2003 Br. J. Cancer pmid:12865927
Kamura S et al. Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway. 2010 Br. J. Cancer pmid:20606682
Marques AR et al. Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours. 2004 Br. J. Cancer pmid:15238980
Kuroda M et al. The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target. 2005 Br. J. Cancer pmid:15655544